William Kevin Kelly, DO
Nonmetastatic castration-resistant prostate cancer (M0CRPC) is a more recently defined clinical state of prostate cancer, for which several approved drugs are now available, explained William Kevin Kelly, DO, in a presentation during the 13th Annual
Interdisciplinary Prostate Cancer Congress®
and Other Genitourinary Malignancies.
... to read the full story